Page last updated: 2024-10-29

indomethacin and Bleeding Between Periods

indomethacin has been researched along with Bleeding Between Periods in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
"Fewer bleeding and spotting days were observed in the 90-day reference period for the 3 indomethacin/levonorgestrel-releasing intrauterine system dose groups than for the levonorgestrel-releasing intrauterine system without indomethacin group."3.30The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial. ( Costescu, D; Fels, LM; Hofmann, BM; Klein, S; Lindenthal, B; Lukkari-Lax, E; Peipert, JF; Reinecke, I; Speer, R; Vieira, CS; Wiesinger, K, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fels, LM3
Costescu, D3
Vieira, CS3
Peipert, JF3
Lukkari-Lax, E3
Hofmann, BM3
Reinecke, I3
Klein, S3
Wiesinger, K3
Lindenthal, B3
Speer, R3

Trials

1 trial available for indomethacin and Bleeding Between Periods

ArticleYear
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    American journal of obstetrics and gynecology, 2023, Volume: 228, Issue:3

    Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med

2023